SEATTLE, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that it will report its third quarter 2025 financial results and provide a business update on Monday, November 10, 2025 after the market closes. The press release will be available on the newsroom section of the Company's website at https://perspectivetherapeu ...

Denifanstat met all primary and secondary endpoints versus placebo and was generally well tolerated in a Phase 3 clinical trial in acne in China conducted by license partner Ascletis Ascletis announced completion of its pre-NDA consultation with China’s NMPA and its plans to submit an NDA for denifanstat in China SAN MATEO, Calif., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metab ...

GOLETA, Calif., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum computing, today announced that a technical paper submitted with collaborators from Thorlabs was accepted to SPIE Photonics West, a conference that occurs January 17 – 22, 2026 at the Moscone Center in San Francisco. The paper reports on Aeluma’s scalable photonics platfor ...

Core Viewpoint - OpenAI is adopting a content policy approach similar to that of Facebook, indicating a shift in its strategy regarding content moderation and policy enforcement [1] Group 1 - The comparison to Facebook suggests that OpenAI may face similar challenges and criticisms related to content management [1] - This shift in policy could impact user engagement and trust in OpenAI's platforms [1] - The statement reflects broader industry trends where tech companies are increasingly scrutinized for their content policies [1]

Oct 24, 2025 7:00 AM Eastern Daylight Time Virtus Investment Partners Announces Financial Results for Third Quarter 2025 Share HARTFORD, Conn.--(BUSINESS WIRE)--Virtus Investment Partners, Inc. (NYSE: VRTS) today reported financial results for the three months ended September 30, 2025. Financial Highlights (Unaudited) | (in millions, except per share data or as noted) | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | Three Months Ended | ThreeMonthsEnded | | | | | | | 9/30/2025 | 9/30/2024 | | Cha ...

Net Sales +3%; Organic Sales +2% Oct 24, 2025 7:00 AM Eastern Daylight Time Diluted EPS $1.95, +21%; Core EPS $1.99, +3% P&G Announces Fiscal Year 2026 First Quarter Results MAINTAINS FISCAL YEAR SALES, EPS GROWTH AND CASH RETURN GUIDANCE Share CINCINNATI--(BUSINESS WIRE)--The Procter & Gamble Company (NYSE:PG) reported first quarter fiscal year 2026 net sales of $22.4 billion, an increase of three percent versus the prior year. Organic sales, which excludes the impacts of foreign exchange and acquisitions ...

Vancouver, British Columbia--(Newsfile Corp. - October 24, 2025) - Q Precious & Battery Metals Corp. (CSE: QMET) (FSE: 0NB) (OTC Pink: BTKRF) (the "Company") announces that it has closed the first tranche of its previously announced private placement offering (the "Offering") (see press release dated October 16, 2025).The Company issued 5,400,000 flow-through units ("FT Units") at a price of $0.09 per FT Unit for gross proceeds of $486,000. Each FT Unit consists of one flow-through common share and one hal ...

ST. LOUIS, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ GS: ADV), announced today that it will release financial results for the third quarter at 7 a.m. EDT on Nov. 6, 2025, followed by a conference call at 8:30 a.m. EDT on the same day. The conference call can be accessed live by dialing 1-800-715-9871 for U.S. callers or 1-646-307-1963 for international callers. The conference ID is 5720569. Approximately three hours after the call, a replay will be available by dialing 1-800-770-203 ...

MRT-6160 inhibited disease pathology, including proteinuria, lymphadenopathy, skin lesion formation, autoantibody production, and organomegaly, in a spontaneous autoimmune disease mouse model Data support the potential of MRT-6160 to address multiple rheumatic autoimmune and inflammatory diseases, including Sjögren’s disease, systemic lupus erythematosus, and rheumatoid arthritis Poster presentation on October 26th at 10:30 am CDT BOSTON, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nas ...

LONDON, Oct. 24, 2025 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology provider, today announced that its AI Enhanced Antora® 1000 computing platform and Cloudpeak® cross-domain software stack will drive the launch of Geely Galaxy EX5 in the United Kingdom themed “Intelligent Everyday”. This marks the start of the large‑scale deliveries of these solutions in core European markets following their rollouts in 33 countries across Southeast Europe, S ...